Evolent Health Inc. (NYSE:EVH) traded down 2.3% during mid-day trading on Wednesday . The company traded as low as $24.07 and last traded at $24.08, with a volume of 108,801 shares trading hands. The stock had previously closed at $24.64.

A number of equities research analysts have recently issued reports on the stock. Canaccord Genuity reissued a “buy” rating on shares of Evolent Health in a research report on Thursday, May 26th. Leerink Swann reaffirmed an “outperform” rating and issued a $20.00 price target on shares of Evolent Health in a research note on Sunday, July 17th. Zacks Investment Research raised Evolent Health from a “sell” rating to a “hold” rating in a research note on Wednesday, May 18th. FBR & Co boosted their price target on Evolent Health from $16.00 to $24.00 and gave the company an “outperform” rating in a research note on Wednesday, July 13th. Finally, Jefferies Group assumed coverage on Evolent Health in a research note on Tuesday, July 26th. They issued a “buy” rating and a $28.00 price target for the company. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $22.50.

The company has a 50-day moving average of $23.52 and a 200 day moving average of $15.33. The firm’s market capitalization is $1.44 billion.

Evolent Health (NYSE:EVH) last issued its earnings results on Thursday, August 4th. The company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.04. During the same quarter in the prior year, the business earned ($0.95) EPS. The company earned $56.50 million during the quarter, compared to the consensus estimate of $51.96 million. The firm’s revenue for the quarter was up 443.3% compared to the same quarter last year. On average, analysts forecast that Evolent Health Inc. will post ($0.54) EPS for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Wells Fargo & Company MN increased its stake in Evolent Health Inc. (NYSE:EVH) by 22.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 808,909 shares of the company’s stock after buying an additional 145,685 shares during the period. Wells Fargo & Company MN owned 1.37% of Evolent Health worth $9,796,000 as of its most recent filing with the SEC.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.